Self-monitoring of blood pressure among women with hypertensive disorders of pregnancy: a systematic review

• Published in: BMC pregnancy and childbirth Vol. 22; no. 1; p. 454
• Main Authors: Yeh, Ping Teresa, Rhee, Dong Keun, Kennedy, Caitlin Elizabeth, Zera, Chloe A, Lucido, Briana, Tunçalp, Özge, Gomez Ponce de Leon, Rodolfo, Narasimhan, Manjulaa
• Format: Journal Article
• Language: English
• Published: England BioMed Central 31.05.2022; BMC
• Subjects: Activities of daily living; Apgar score; Blood pressure; Clinical trials; COVID-19; Hypertension; Intervention; Maternal & child health; Mortality; Population; Pre-eclampsia; Preeclampsia; Pregnancy; Prenatal care; Self-care; Self-monitoring; Systematic review; Womens health; Hypertension; Pregnancy; Blood pressure; Self-monitoring; Pre-eclampsia; Self-care
• ISSN: 1471-2393; 1471-2393
• DOI: 10.1186/s12884-022-04751-7

The World Health Organization (WHO) recommends self-monitoring of blood pressure (SMBP) for hypertension management. In addition, during the COVID-19 response, WHO guidance also recommends SMBP supported by health workers although more evidence is needed on whether SMBP of pregnant individuals with hypertension (gestational hypertension, chronic hypertension, or pre-eclampsia) may assist in early detection of pre-eclampsia, increase end-user autonomy and empowerment, and reduce health system burden. To expand the evidence base for WHO guideline on self-care interventions, we conducted a systematic review of SMBP during pregnancy on maternal and neonatal outcomes. We searched for publications that compared SMBP with clinic-based monitoring during antenatal care. We included studies measuring any of the following outcomes: maternal mortality, pre-eclampsia, long-term risk and complications, autonomy, HELLP syndrome, C-section, antenatal hospital admission, adverse pregnancy outcomes, device-related issues, follow-up care with appropriate management, mental health and well-being, social harms, stillbirth or perinatal death, birthweight/size for gestational age, and Apgar score. After abstract screening and full-text review, we extracted data using standardized forms and summarized findings. We also reviewed studies assessing values and preferences as well as costs of SMBP. We identified 6 studies meeting inclusion criteria for the effectiveness of SMBP, 6 studies on values and preferences, and 1 study on costs. All were from high-income countries. Overall, when comparing SMBP with clinic-monitoring, there was no difference in the risks for most of the outcomes for which data were available, though there was some evidence of increased risk of C-section among pregnant women with chronic hypertension. Most end-users and providers supported SMBP, motivated by ease of use, convenience, self-empowerment and reduced anxiety. One study found SMBP would lower health sector costs. Limited evidence suggests that SMBP during pregnancy is feasible and acceptable, and generally associated with maternal and neonatal health outcomes similar to clinic-based monitoring. However, more research is needed in resource-limited settings. PROSPERO CRD42021233839 .